Kathy L. Hibbs Sells 38,551 Shares of 23andMe Holding Co. (NASDAQ:ME) Stock

23andMe Holding Co. (NASDAQ:ME) insider Kathy L. Hibbs sold 38,551 shares of the business’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $0.49, for a total transaction of $18,889.99. Following the transaction, the insider now directly owns 1,252,315 shares of the company’s stock, valued at approximately $613,634.35. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

23andMe Trading Up 2.3 %

ME opened at $0.50 on Wednesday. 23andMe Holding Co. has a 1-year low of $0.35 and a 1-year high of $2.21. The business has a 50 day moving average of $0.49 and a 200-day moving average of $0.69. The stock has a market capitalization of $240.30 million, a price-to-earnings ratio of -0.45 and a beta of 1.24.

23andMe (NASDAQ:ME) last posted its quarterly earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share (EPS) for the quarter. The company had revenue of $44.75 million during the quarter, compared to analyst estimates of $56.30 million. 23andMe had a negative return on equity of 52.99% and a negative net margin of 210.48%.

Wall Street Analysts Forecast Growth

Separately, Citigroup decreased their target price on 23andMe from $0.85 to $0.47 and set a “neutral” rating for the company in a research note on Tuesday, April 16th.

Institutional Investors Weigh In On 23andMe

Institutional investors have recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. raised its stake in shares of 23andMe by 361.0% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 36,049 shares of the company’s stock valued at $33,000 after buying an additional 28,229 shares in the last quarter. Wittenberg Investment Management Inc. raised its position in 23andMe by 88.8% in the third quarter. Wittenberg Investment Management Inc. now owns 1,144,484 shares of the company’s stock worth $1,119,000 after purchasing an additional 538,230 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of 23andMe by 3.1% in the 3rd quarter. Vanguard Group Inc. now owns 28,145,216 shares of the company’s stock valued at $27,518,000 after purchasing an additional 834,504 shares during the period. Raymond James & Associates raised its holdings in shares of 23andMe by 82.4% in the 4th quarter. Raymond James & Associates now owns 65,973 shares of the company’s stock worth $60,000 after buying an additional 29,800 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC bought a new position in shares of 23andMe during the 3rd quarter worth approximately $37,000. 36.10% of the stock is owned by institutional investors and hedge funds.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.